Hormone Therapy Blood Clot Risk Study
A new study examines the thromboembolic risks of menopausal hormone therapy. Separately, research reveals significant gender disparities in the diagnosis of autoimmune conditions.
Two new studies highlight critical issues in women's health. The first investigates the cardiovascular risks associated with menopausal hormone therapy, while the second reveals stark gender biases in diagnosing autoimmune diseases.
Hormone Therapy and Clotting Risk
A large Danish registry study has provided new data on the thromboembolic risks of menopausal hormone therapy. The research analyzed nearly 9,800 women with venous thromboembolism, over 18,000 with ischemic stroke, and just under 12,000 who had a myocardial infarction, all of whom had used hormone therapy. These women were matched with others who had never taken it. The study found that oral estrogen formulations were linked to an increased risk of these cardiovascular events.
The investigation specifically highlighted the danger associated with oral estrogen. The data suggests that the route of administration is a key factor in risk. This research adds to the ongoing, complex conversation about the safety profile of hormone replacement therapy for menopausal women, emphasizing the need for personalized risk assessment.
Autoimmune Disease Diagnosis Bias
Women with autoimmune conditions face significant disadvantages in obtaining accurate diagnoses compared to men. A study from the University of Cambridge and the University of East Anglia, involving more than 6,600 patients, found that women are far more likely to be told their physical symptoms are psychological. After accounting for various factors, women were 46% more likely to report receiving a psychiatric misdiagnosis and 74% more likely to have symptoms labeled as psychosomatic.
The research also uncovered major delays in diagnosis. While the most frequently reported time to diagnosis for men was less than three months, for women it was typically one to two years. Lead researcher Melanie Sloan stated, "The damage caused to women by these types of misdiagnosis can be very long lasting." She added that the findings highlight how psychological explanations can be given too quickly, a problem affecting both sexes but disproportionately impacting women.
Common conditions among female participants included autoimmune thyroid disease, like Hashimoto's and Graves' disease, and systemic lupus. The study authors suggest historical biases in medicine, which position women as less credible reporters of symptoms, may persist and contribute to these diagnostic challenges and delays in treatment.
